Angiotensinogen
| GO Term |
|---|
| extracellular space |
| GO Term |
|---|
| type 1 angiotensin receptor binding |
| type 2 angiotensin receptor binding |
| serine-type endopeptidase inhibitor activity |
| hormone activity |
| Pathway Name | Organism |
|---|---|
| G alpha (i) signalling events | Rattus norvegicus |
| G alpha (q) signalling events | Rattus norvegicus |
| Metabolism of Angiotensinogen to Angiotensins | Rattus norvegicus |
| Peptide ligand-binding receptors | Rattus norvegicus |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0080322 | polycystic kidney disease | |
| DOID:10763 | hypertension | |
| DOID:10808 | gastric ulcer | |
| DOID:11446 | sciatic neuropathy | |
| DOID:1875 | impotence | |
| DOID:1936 | atherosclerosis | |
| DOID:3770 | pulmonary fibrosis | |
| DOID:5844 | myocardial infarction | |
| DOID:6432 | pulmonary hypertension | |
| DOID:8947 | diabetic retinopathy |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.4.0
Last updated: December 8, 2025